Clearance Summary
NX01 (NX01) received FDA 510(k) clearance under submission number K251550, sponsored by Naox Technologies Sas. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2025-11-25.
- Submission: K251550
- Applicant / Sponsor: Naox Technologies Sas
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.1400
- Decision date: 2025-11-25
Classification & Regulation
This clearance is catalogued under FDA product code OMC and 21 CFR 882.1400, within the Neurology review panel as a Class II device.